Literature DB >> 18821044

High rate of restenosis after carotid artery stenting in patients with high-grade internal carotid artery stenosis. Medium-term follow-up.

Judith U Harrer1, Ralf Morschel, Michael Mull, Christoph M Kosinski.   

Abstract

OBJECTIVE: Carotid endarterectomy (CEA) is the gold-standard procedure for the majority of patients with high-grade symptomatic internal carotid artery stenosis and also for specified high-grade asymptomatic stenoses; however, a proportion of patients are treated with carotid endovascular therapy. We aimed to document medium-term clinical and neurosonographical outcome after carotid artery stenting (CAS).
METHODS: 53 patients (mean age: 65 +/- 8 years) with high-grade (> or = 70 % by means of duplex sonography) carotid artery stenosis were enrolled into the study. Nineteen patients had asymptomatic, 34 patients had symptomatic stenoses. All patients had a pre-interventional CT, Doppler and duplex sonography, and digital subtraction angiography (DSA) or magnetic resonance angiography (MRA) prior to the procedural DSA. All patients were offered CEA as the gold-standard procedure and as an alternative to CAS. Both clinical and Duplex sonographical follow-up was obtained at day 1 and 7, month 1, month 3, month 6, month 12, and every subsequent 6 months after the procedure. Mean follow-up time was 22 +/- 1.6 months (+/- SEM).
RESULTS: 2/53 patients suffered from stroke. A further 2 patients suffered from carotid artery occlusion shortly after CAS. The cumulative rate of restenosis during follow-up was 24.5 % (13/53). Four of these (7.5 %) were of high-grade and led to further interventional or surgical therapy.
CONCLUSIONS: A high rate of restenosis was found during follow-up after CAS. Our analysis of non-selected patients emphasizes that CEA remains the gold-standard procedure for the treatment of symptomatic internal carotid artery stenosis. The frequently performed endovascular treatment of carotid stenosis outside the setting of a randomized controlled trial is not supported by our data.

Entities:  

Mesh:

Year:  2008        PMID: 18821044     DOI: 10.1007/s00415-008-0875-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Endarterectomy versus stenting for carotid stenosis.

Authors:  Robert F Bonvini; Marc Righini
Journal:  N Engl J Med       Date:  2007-01-18       Impact factor: 91.245

2.  30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial.

Authors:  P A Ringleb; J Allenberg; H Brückmann; H-H Eckstein; G Fraedrich; M Hartmann; M Hennerici; O Jansen; G Klein; A Kunze; P Marx; K Niederkorn; W Schmiedt; L Solymosi; R Stingele; H Zeumer; W Hacke
Journal:  Lancet       Date:  2006-10-07       Impact factor: 79.321

3.  Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis.

Authors:  Jean-Louis Mas; Gilles Chatellier; Bernard Beyssen; Alain Branchereau; Thierry Moulin; Jean-Pierre Becquemin; Vincent Larrue; Michel Lièvre; Didier Leys; Jean-François Bonneville; Jacques Watelet; Jean-Pierre Pruvo; Jean-François Albucher; Alain Viguier; Philippe Piquet; Pierre Garnier; Fausto Viader; Emmanuel Touzé; Maurice Giroud; Hassan Hosseini; Jean-Christophe Pillet; Pascal Favrole; Jean-Philippe Neau; Xavier Ducrocq
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 4.  What is the current status of angioplasty vs endarterectomy in patients with asymptomatic carotid artery disease?

Authors:  A R Naylor
Journal:  J Cardiovasc Surg (Torino)       Date:  2007-04       Impact factor: 1.888

5.  Restenosis after carotid angioplasty, stenting, or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS).

Authors:  Dominick J H McCabe; Anthony C Pereira; Andrew Clifton; J Martin Bland; Martin M Brown
Journal:  Stroke       Date:  2005-01-13       Impact factor: 7.914

6.  Clinical advisory: carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis.

Authors: 
Journal:  Stroke       Date:  1994-12       Impact factor: 7.914

7.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Authors:  A Halliday; A Mansfield; J Marro; C Peto; R Peto; J Potter; D Thomas
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

8.  Timing of stenting of symptomatic carotid stenosis is predictive of 30-day outcome.

Authors:  R Topakian; A M Strasak; M Sonnberger; H-P Haring; K Nussbaumer; J Trenkler; F T Aichner
Journal:  Eur J Neurol       Date:  2007-06       Impact factor: 6.089

9.  Surgical and oncology trials for rectal cancer: who will participate?

Authors:  James D Harrison; Michael J Solomon; Jane M Young; Alan Meagher; George Hruby; Glenn Salkeld; Stephen Clarke
Journal:  Surgery       Date:  2007-07       Impact factor: 3.982

10.  Neuropsychological consequences of endarterectomy and endovascular angioplasty with stent placement for treatment of symptomatic carotid stenosis: a prospective randomised study.

Authors:  Karsten Witt; Katharina Börsch; Christine Daniels; Knut Walluscheck; Karsten Alfke; Olav Jansen; Norbert Czech; Günther Deuschl; Robert Stingele
Journal:  J Neurol       Date:  2007-07-31       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.